Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis

Published:2009-03-25 Issue:9 Volume:48 Page:1069-1072
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Sawada T.,Inokuma S.,Sato T.,Otsuka T.,Saeki Y.,Takeuchi T.,Matsuda T.,Takemura T.,Sagawa A.,

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/48/9/1069/5048912/kep052.pdf

Reference19 articles.

1. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis

2. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate

3. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year followup study

4. Leflunomide use during the first 33 months after food and drug administration approval: Experience with a national cohort of 3,325 patients

5. Interstitial lung disease and disease modifying anti-rheumatic drugs

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors of incident lung diseases and the impact of DMARDs in rheumatoid arthritis patients: a longitudinal study;2024-07-23

2. Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study;Arthritis Research & Therapy;2024-07-19

3. Drug-induced interstitial lung disease: a narrative review of a clinical conundrum;Expert Review of Respiratory Medicine;2024-02

4. Japanese clinical practice guide 2022 for hypersensitivity pneumonitis;Respiratory Investigation;2024-01

5. A Lethal Case of Acute Exacerbation of Rheumatoid Arthritis – Related Interstitial Lung Disease Induced by the COVID Vaccine.;Respiratory Medicine Case Reports;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3